Drug regulators are increasingly pushing for reduced animal testing, particularly in the EU, where it was recently announced that the use of the traditional rabbit pyrogen test (RPT) will be abolished next year as a requirement for controlling drug product pyrogenicity.
Jo Varshney, founder and CEO of VeriSIM Life, a US company that uses AI to help pharmaceutical companies improve drug discovery and development, told the Pink Sheet that she foresees regulatory agencies asking
Key Takeaways
-
Regulators such as the US FDA and the EMA are beginning to accept alternatives to animal testing in pharmaceutical R&D.
-
VeriSIM Life’s CEO says that the company’s hybrid AI platform can help companies to reduce animal testing by running simulations that reveal which tests are necessary, and which are not
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?